Accurate and Robust Quantification of Circulating Fetal and Total DNA in Maternal Plasma from 5 to 41 Weeks of Gestation

This publication has 49 references indexed in Scilit:

• Improvement in Sensitivity of Allele-specific PCR Facilitates Reliable Noninvasive Prenatal Detection of Cystic Fibrosis
  Clinical Chemistry, 2004
• Rapid Screening of Multiple β-Globin Gene Mutations by Real-Time PCR on the LightCycler: Application to Carrier Screening and Prenatal Diagnosis of Thalassemia Syndromes
  Clinical Chemistry, 2003
• A new approach to antenatal screening for Fragile X syndrome
  Prenatal Diagnosis, 2003
• Huntington disease–unaffected fetus diagnosed from maternal plasma using QF‐PCR
  Prenatal Diagnosis, 2003
• Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma
  Prenatal Diagnosis, 2002
• Prenatal exclusion of β thalassaemia major by examination of maternal plasma
  The Lancet, 2002
• First‐trimester fetal sex determination in maternal serum using real‐time PCR
  Prenatal Diagnosis, 2001
• Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma
  New England Journal of Medicine, 1998
• Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis
  American Journal of Human Genetics, 1998
• Presence of fetal DNA in maternal plasma and serum
  The Lancet, 1997